Aktive farmaceutiske ingredienser
| Gestagen og østrogen | |||
| Produktnavn | Specifikation | Godkendt | CAS-nr. |
| Progesteron | CP/EP/USP/JP | CEP/EU-GMP/FDA | 57-83-0 |
| Pregnenolon | In-house |
Kosher | 145-13-1 |
| Medroxyprogesteron Acetat | CP/EP/USP/JP | DMF/GMP | 71-58-9 |
| Megestrolacetat | CP/EP/USP | DMF i gang | 595-33-5 |
| Mifepriston | CP/IP | DMF/GMP | 84371-65-3 |
| Cyproteronacetat | CP/EP/IP/KP | CEP/TGA/EU-GMP | 427-51-0 |
| Levonorgestrel | CP/EP/USP/IP | CEP/GMP | 797-63-7 |
| Norethisteron |
CP/EP/USP/JP |
DMF i gang |
68-22-4 |
| Norethisteronacetat |
EP/USP |
DMF i gang |
51-98-9 |
| Norethisteron Enanthate |
In-house |
Under R&D |
3836-23-5 |
| Drospirenon | EP/USP | DMF | 67392-87-4 |
| Gestodene | CP/EP | DMF/GMP | 60282-87-3 |
| Østradiol | CP/EP/USP/KP | DMF/GMP/WC | 35380-71-3 |
| Estriol | CP/EP/USP | Under R&D | 50-27- 1 |
| Ethinylestradiol | CP/EP/USP | GMP | 57-63-6 |
| Østradiol Valerat | CP/EP/USP/KP | DMF | 979-32-8 |
| Østradiol Cypionate |
USP | DMF i gang |
313-06-4 |
| Promestriene |
In-house |
Under R&D |
39219-28-8 |
| Tibolone | CP/EP | DMF/GMP | 5630-53-5 |
| Dienogest | EP | CEP/GMP | 65928-58-7 |
| Fulvestrant | EP/USP | Under R&D | 129453-61-8 |
| Exemestan | CP/EP/USP | Under R&D | 107868-30-4 |
| androgen | |||
| Produktnavn | Specifikation | Godkendt | CAS-nr. |
| Finasteride | CP/EP/USP | CEP/FDA/PMDA/GMP | 98319-26-7 |
| Dutasteride | EP/USP | CEP/FDA | 164656-23-9 |
| Abirateronacetat | CP/USP | DMF/GMP/WC | 154229-18-2 |
| Darolutamid |
In-house |
Under R&D |
1297538-32-9 |
| Testosteron | CP/EP/USP | CEP/FDA/WC | 58-22-0 |
| Testosteron undecanoat | CP | DMF/WC | 5949-44-0 |
| Testosteron Cypionate | USP | DMF | 58-20-8 |
| Testosteron Enanthate |
USP/JP | Under R&D |
315-37-7 |
| Testosteron propionat |
CP/EP/USP/JP |
Under R&D |
57-85-2 |
| DHEA | FP/In-house | DMF/WC/Kosher | 53-43-0 |
| Clascoterone | In-house | DMF i gang | 19608-29-8 |
| Kortikalt hormon | |||
| Produktnavn | Specifikation | Godkendt | CAS-nr. |
| Budesonid | CP/EP/USP/JP | CEP/FDA/GMP | 51333-22-3 |
| Desonid | CP/USP | DMF/GMP | 638-94-8 |
| Eplerenon | EP | CEP i gang | 107724-20-9 |
| Methylprednisolon | CP/EP/USP/JP | DMF/GMP | 83-43-2 |
| Methylprednisolon Hemisuccinat | CP/EP/USP | DMF/GMP | 2921-57-5 |
| Fluticasonpropionat | CP/EP/USP | DMF | 80474-14-2 |
| Flutikasonfuroat | CP/EP | DMF i gang | 397864-44-7 |
| Mometasonfuroat |
CP/EP/USP |
DMF i gang |
Vandfri (83919-23-7) Monohydrat (141646-00-6) |
| Deflazacort |
In-house |
Under R&D |
14484-47-0 |
| Andre | |||
| Produktnavn | Specifikation | Godkendt | CAS-nr. |
| Oxcarbazepin | CP/EP/USP/IP | CEP/FDA/GMP | 28721-07-5 |
| Eslicarbazepinacetat | CP/USP | DMF | 236395-14-5 |
| Ganciclovir | CP/EP/USP | DMF/GMP | 82410-32-0 |
| Valganciclovir Hydrochlorid | USP/EP | CEP i gang | 175865-59-5 |
| Oseltamivir fosfat | CP/EP/USP | DMF | 204255-11-8 |
| Baloxavir Marboxil | In-house | Under R&D | 1985606-14-1 |
| Revefenacin | In-house | DMF | 864750-70-9 |
| Mirabegron | CP/EP | DMF | 223673-61-8 |
| Vibegron |
In-house |
Under R&D |
1190389-15-1 |
| Escitalopram Oxalat | CP/EP/USP | DMF i gang | 219861-08-2 |
| Citalopram Hydrobromid |
CP/EP/USP |
DMF i gang |
59729-32-7 |
| Cariprazin hydrochlorid | In-house | DMF | 1083076-69-0 |
| Lasmiditansuccinat | In-house | DMF | 439239-92-6 |
| Luliconazol | In-house | DMF | 187164-19-8 |
| Nintedanib Esylate |
In-house |
FDA/DMF/WC |
656247-18-6 |
| Apalutami | In-house | DMF | 956104-40-8 |
| Tadalafil | CP/EP/USP | Under R&D | 171596-29-5 |
| Relugolix | In-house | DMF i gang | 737789-87-6 |
| Ruxolitinib fosfat |
In-house |
DMF i gang |
1092939-17-7 |
| Abemaciclib |
In-house |
Under R&D |
1231929-97-7 |
| Phloroglucinol | CP/EP | DMF | 108-73-6 |
| 1,3,5-trimethoxybenzen |
CP/In-house |
GMP |
621-23-8 |
| Ursodeoxycholsyre | EP/USP/JP | Under R&D | 128-13-2 |
| Tauroursodeoxycholsyre |
In-house |
Under R&D |
14605-22-2 |
| Kolesterol |
CP/EP/USP/JP |
Under R&D |
57-88-5 |
| Omega-3-syre ethylethere 90 |
EP/USP |
DMF i gang |
—— |
| Mellemkædede triglycerider |
CP/USP/EP |
DMF |
—— |
| Benzalkoniumchlorid |
USP/EP/JP |
CEP i gang |
8001-54-5 |
| Olivenolie (til injektion) |
CP/USP/EP/JP |
DMF i gang |
8001-25-0 |
| Ægfosfolipider (til injektion) |
CP/USP/EP |
DMF |
93685-90-6 |
| Mellemmåltid |
In-house |
DMF i gang |
203787-91-1 |
Progesteron har EP, USP, CP, JP, IP og KP specifikationer.CEP tilgængelig, EU-GMP,FDA godkendt.
Finasteride har EP, USP, CP, IP, JP specifikationer.CEP tilgængelig, FDA, PMDA og GMP godkendt.
Budesonid har USP, EP specifikationer. CEP, GMP og FDA godkendt.
Dutasteride har EP, USP, CP, IP, JP specifikation. CEP og FDA tilgængelige.
Desonide har USP- og EP-specifikationer. DMF tilgængelig.
Methylprednisolon har USP, EP, IP, JP og KP specifikationer. DMF og toilet til rådighed.